A Multi center study of the Bruton's Tyrosine Kinase (BTK) inhibitor, Ibrutinib in combination with MEDI4736

Clinical Trial Grant

Duke Scholars

Principal Investigator Niharika Bansal Mettu Medicine, Medical Oncology

Awarded By

Pharmacyclics, Inc.

Start Date

October 1, 2015

End Date

February 22, 2018

Awarded By

Pharmacyclics, Inc.

Start Date

October 1, 2015

End Date

February 22, 2018